Navigation Links
CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal

in developing RNAi therapeutics."

Steven A. Kriegsman, President and CEO of CytRx, added, "RNAi therapeutics holds tremendous promise as cures for diseases caused by proteins that cannot be targeted by conventional drugs. We are pleased that Dr. Rana and his colleagues are receiving recognition from the scientific community in developing a breakthrough that could expedite the development of important therapeutic treatments."

About CytRx Corporation

Los Angeles, California-based CytRx Corporation is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics. The Company owns three clinical-stage compounds based on its small molecule "molecular chaperone" co-induction technology. In September 2006 CytRx announced that arimoclomol was shown to be safe and well tolerated at all three doses tested in its Phase IIa clinical trial in patients with ALS. The Company expects to announce results of its completed open-label extension trial in the second quarter of 2007. The Company plans to enter a Phase IIb clinical trial with arimoclomol in ALS in the second half of 2007, subject to U.S. Food and Drug Administration (FDA) acceptance. The FDA has granted Fast Track designation and Orphan Drug status to arimoclomol for the treatment of ALS and has also been granted orphan medicinal product status for the treatment of ALS by the European Commission. The Company is also developing a potential Phase II clinical plan for arimoclomol in stroke recovery. For more information on the Company, visit www.cytrx.com.

About RXi Pharmaceuticals Corporation

Worcester, Massachusetts-based RXi Pharmaceuticals Corporation, a majority-owned subsidiary of CytRx Corporation, is a biopharmaceutical research and development company that focuses on developing RNAi-based therapeutics for the treatment of human disease. RXi's initial focus is on neurodegenerative diseases, oncology, type 2 diabetes and obesity. RXi
'"/>




Page: 1 2 3 4

Related medicine technology :

1. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
2. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
3. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease

Post Your Comments:
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinke...is available in its catalogue: ,, Decubitus Ul... ,, http://www.reportlinker.com/p0164283/Decu...t-Review.html ,, Decubitus Ulcers are lesions...ressure of the patient,s bodyweight. Pressure ulce...
(Date:11/30/2009)...OOMFIELD HILLS, Mich., Nov. 30 eHe...site dedicated exclusively to products approved fo...unt (FSA/HSA) claims. The site is also the first ... medications, saving shoppers up to 75 percent on ...elps cure two common healthcare headaches - high c...
(Date:11/30/2009)...HICAGO, Nov. 30 MedPro Imaging, a ... solutions, will showcase leading ultrasound solut...nd Siemens X300 Premium Edition during the company...erica (RSNA) conference, being held in Chicago Nov...o Imaging markets ultrasound products and services...
Breaking Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX 14301 1DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX 14301 2DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX 14301 3DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX 14301 4The National Park Foundation and Olympus Announce Winner of the First Ever Your Parks Video Challenge 14298 1The National Park Foundation and Olympus Announce Winner of the First Ever Your Parks Video Challenge 14298 2The National Park Foundation and Olympus Announce Winner of the First Ever Your Parks Video Challenge 14298 3The National Park Foundation and Olympus Announce Winner of the First Ever Your Parks Video Challenge 14298 4ParagonRx Names Ellen M Derrico To Chief Marketing Executive Post 5109 1
...Calif., June 04, 2007 /PRNewswire-FirstCall/ -- Ko... Phase 1 clinical,trial showing that KOS-1584/R164...demonstrated promising antitumor,activity and tole...1645 showed activity in 32% of patients (13 of 41,...-small cell lung,ovarian, breast, prostate, head ...
... Mass.--(BUSINESS WIRE)--Jun 4, 2007 - Molecular I...ced today that the,company will present the result...l meeting of the Society of Nuclear Medicine (SNM)...a on Azedra(TM),(Ultratrace (131)I-MIBG), the comp...ndidate for the treatment of malignant,neuroendocr...
Other Medicine Technology:Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 2Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 3Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 4Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 5Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 4
(Date:11/30/2009)... , PHILADELPHIA, Pennsylvani... - Exclusive Updates From Elsevier,s Top Thought ...RRA Momentum , Elsevier, a world leader i...eb-based and electronic health record (EHR) integr...rce center for American Recovery and Reinvestment,...
(Date:11/30/2009)... Association of Urology (EAU) and Europa Uomo, the... prostate cancer, have entered into an,affiliated... to increase and improve,patient awareness in Eur...sor Per-Anders Abrahamsson, Secretary-General of t...tnership, Europa Uomo will gain access to the late...
(Date:11/30/2009)...r 30, 2009A pet owner knows the enormous joy and c...roubled times. Most pets are considered important .... A growing body of research now documents the val...elderly care, mental illness, physical impairment,...bilitation of incarcerated youth and adults. , I...
(Date:11/30/2009)... of Navarra Hospital has launched a series of clin...immunotherapy treatment. This approach involves th...om healthy and tumour cells from the patient him o...e of the most aggressive and frequent malignant tu...ating patients combined with the standard, first-l...
(Date:11/30/2009)... Author of "My Two-Year Old Eats Oct...en who love to eat everything. , ... picky eater in your house? Do you find yourself ...ew short online videos – one focusing on pac...ird on answers for real-life parents’ questi...
Breaking Medicine News(10 mins):Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:The therapeutic benefits of the human-animal bond 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3
...that two thirds of those who take herbal supplemen...g so. In other words , those using herbal medicine...blind faith and do not care to check the credentia...02 national health survey of more than 30,000 U.S....
...d to control the movement of Escherichia coli in a... have opened the door to powerful new opportuniti...thetic biology. Their findings are published onlin...chemistry, and graduate student Shana Topp success...
...w blessings of being ill' - Sara Moss-Wolfe ...t, and compassion are traits sacrosanct to the nur...are its greatest virtues. It might seem implausibl...time, and needs no introduction - Florence Nightin...
...sity of Illinois at Chicago explain in the May 11 ...n the heart's pacemaker to slow the rapid beating...naline. A single cell in the upper right c...ell - beats faster or slower to induce a rhythmic ...
...shion accessories, United Colors of Benetton has u...to make the hot , sweaty summers fresh and fragran...iations - Woman, Man and Unisex. The Benet... the perfumes. "Cotton is an element that ...
...nai Medical Center in Los Angeles have reported th...eart from a patient who had died and retransplant...this is the first time this has been done with a t...ion is very rare. The second patient was a 45...
Other Medicine News:Health News:Blind Faith Dictates Use Of Herbal Supplements In Many 2Health News:Scientists Equip Bacteria With Custom Chemo-Navigational System 2Health News:Nurturing Our Nurses for Healthcare Par Excellence 2Health News:Nurturing Our Nurses for Healthcare Par Excellence 3Health News:Nurturing Our Nurses for Healthcare Par Excellence 4Health News:Slowing the Racing Heart 2Health News:Transplanted Heart Goes to a Second Recipient in a Rare Surgery 2
Ellik Evacuator
Ellik Bladder Evacuator-Disposable
Urology C-Arm Table
Aspect100U
Medicine Products: